10% Enrofloxacin Oral Solution
.png)
.png)
.png)
.png)
Ukwakheka
I-100ml iqukethe i-10g ye-Enrofloxacin
Ukubukeka
Lo mkhiqizo cishe awunambala uketshezi olucacile oluphuzi ngokuphuzi
Isenzo se-Pharmacological
I-Empagliflozin isidakamizwa esilwa ne-bactericidal esibanzi esinikezelwe kuma-fluoroquinolones.Inomphumela omuhle ku-Escherichia coli, i-Salmonella, i-Klebsiella, i-Brucella, i-Pasteurella, i-Actinobacillus pleuropneumoniae, i-Erysipelothrix, i-Proteus, i-Serratia marcescens, i-Corynebacterium pyogenes, i-Potter septicum, i-Staphylococcus aureus, i-Mycoplasmsacmonaseudocus, i-Chlamycoccus acptocus, i-Chlamycoccus, i-Chlamycoccus, i-Chlamycoccus aureus, i-Chlamycoccus aureus, i-Chlamycoccus aureus, i-Chlamycoccus, i-Pyogene, kanye nomphumela obuthakathaka kubhaktheriya ye-anaerobic.Inomphumela obalulekile we-post-antibacterial kuma-bacteria atholakala kalula.Indlela elwa namagciwane yokusebenza kwalo mkhiqizo ukuvimbela i-DNA gyrase yebhaktheriya, iphazamise ukuphindaphinda, ukulotshwa nokukhanda kanye nokuhlanganiswa kabusha kwe-DNA yebhaktheriya, futhi amabhaktheriya awakwazi ukukhula futhi aziphindaphinde ngokujwayelekile futhi afe.
I-Pharmacokinetics
Lo mkhiqizo umunca kahle ngemva kokuphathwa ngomlomo ezilwaneni eziningi.I-bioavailability yokuphathwa ngomlomo ezinkukhuni ingama-62.2% ~ 84%, esatshalaliswa kabanzi ezinkukhuni futhi ingangena kahle ezicutshini nakuketshezi lomzimba (okuhlanganisa namathambo).Ngaphandle koketshezi lwe-cerebrospinal, ukugcwala komuthi cishe kuzo zonke izicubu kuphezulu kunalokho okuse-plasma.I-Hepatic metabolism iwukukhipha ikakhulukazi iqembu le-ethyl le-7-piperazine ring ukukhiqiza i-ciprofloxacin, kulandelwa i-oxidation ne-glucuronic acid conjugation.Ikhishwa ikakhulukazi yizinso (ngokukhishwa kwe-tubular kanye nokuhlunga kwe-glomerular), futhi i-15% kuya ku-50% ikhishwa ingashintshiwe emchameni.Ukuqedwa kwesigamu sempilo yalo mkhiqizo ngemuva kokuphathwa ngomlomo ezinkukhu ngamahora angu-9.1 kuya kwangu-14.2
Ukusebenzisana kwezidakamizwa
(1) Lo mkhiqizo unomphumela we-synergistic uhlanganiswe nama-aminoglycosides noma ama-penicillin ane-spectrum ebanzi.
Ama-ion ensimbi esindayo afana ne-Ca2 +, Mg2 +, Fe3 + ne-Al3 + angachelate ngalo mkhiqizo futhi athinte ukumuncwa.
(2) Uma isetshenziswa ihlanganiswe ne-theophylline ne-caffeine, izinga lokubopha amaprotheni e-plasma lingancishiswa, ukugxila kwe-theophylline ne-caffeine kunganyuka ngokungavamile, ngisho nezimpawu zobuthi be-theophylline zingenzeka.
(3) Lo mkhiqizo unomphumela wokuvimbela ama-enzyme ezidakamizwa ze-hepatic, anganciphisa izinga lokusulwa kwezidakamizwa ezigaywe kakhulu esibindi futhi andise ukugcwala kwe-plasma.
(4)Isenzo nokusetshenziswa: Imithi elwa namagciwane e-Fluoroquinolone.Isetshenziselwa izifo ezibangelwa amagciwane kanye nokutheleleka kwe-mycoplasma ezinkukhu.
Umthamo kanye nokuphatha
Isiphuzo esihlanganisiwe: 0.5 ~ 0.75 ml yenkukhu nge-1 L yamanzi.
Ukusabela okubi
(1) Ukonakala koqwanga kwenzeka ezilwaneni ezisencane, okuthinta ukukhula kwamathambo futhi kubangele ukuxhwala nobuhlungu.
(2) Ukusabela kwesistimu yokugaya kubandakanya ukulahlekelwa ukudla, isifo sohudo, njll.
Izinyathelo zokuzivikela
I-contraindicated ekubekeni izinkukhu ngesikhathi sokubeka
Isikhathi sokuhoxa
Izinyoni: izinsuku ezingu-8
Isitoreji
Ivalwe futhi igcinwe, ivikelwe ekukhanyeni.
I-Hebei Veyong Pharmaceutical Co., Ltd, yasungulwa ngo-2002, etholakala eShijiazhuang City, eSifundazweni saseHebei, eChina, eduze kweNhloko-dolobha yaseBeijing.Uyibhizinisi elikhulu lemithi yezilwane eqinisekiswe yi-GMP, ene-R&D, ukukhiqizwa nokudayiswa kwama-API wezilwane, amalungiselelo, okuphakelayo okuxutshwe ngaphambili nezithasiselo zokudla.NjengeSikhungo Sezobuchwepheshe Sesifundazwe, i-Veyong isungule uhlelo olusha lwe-R&D lomuthi omusha wezilwane, futhi iyibhizinisi lezobuchwepheshe elaziwa kuzwelonke elisekelwe kudokotela wezilwane, kunochwepheshe abangama-65.I-Veyong inezisekelo ezimbili zokukhiqiza: i-Shijiazhuang ne-Ordos, lapho isisekelo se-Shijiazhuang sihlanganisa indawo engu-78,706 m2, nemikhiqizo ye-API engu-13 ehlanganisa i-Ivermectin, i-Eprinomectin, i-Tiamulin Fumarate, i-Oxytetracycline hydrochloride ects, kanye ne-11, imigqa yokukhiqiza ye-powder yokulungiselela , premix, bolus, izibulala-zinambuzane nesibulala-magciwane, njll.I-Veyong ihlinzeka ngama-API, amalungiselelo angaphezu kwe-100 elebula uqobo, kanye nesevisi ye-OEM & ODM.
I-Veyong ibheka ukubaluleka okukhulu ekuphathweni kohlelo lwe-EHS(Imvelo, Impilo Nokuphepha), futhi yathola izitifiketi ze-ISO14001 ne-OHSAS18001.I-Veyong isohlwini lwamasu amabhizinisi ezimboni asafufusa esifundazweni sase-Hebei futhi ingaqinisekisa ukuhlinzekwa okuqhubekayo kwemikhiqizo.
I-Veyong yasungula uhlelo oluphelele lokuphatha ikhwalithi, yathola isitifiketi se-ISO9001, isitifiketi se-China GMP, isitifiketi se-APVMA GMP yase-Australia, isitifiketi se-Ethiopia GMP, isitifiketi se-Ivermectin CEP, futhi yaphumelela ukuhlolwa kwe-US FDA.I-Veyong inethimba elichwepheshile lokubhalisa, ukuthengisa kanye nenkonzo yezobuchwepheshe, inkampani yethu ithole ukwethenjwa nokusekelwa kumakhasimende amaningi ngekhwalithi yomkhiqizo omuhle kakhulu, ikhwalithi ephezulu yokuthengisa kwangaphambili kanye nenkonzo yangemuva kokuthengisa, ukuphathwa okungathi sína nokwesayensi.I-Veyong yenze ukubambisana kwesikhathi eside namabhizinisi amaningi emithi yezilwane aziwa emhlabeni wonke ngemikhiqizo ethunyelwa eYurophu, eNingizimu Melika, eMpumalanga Ephakathi, e-Afrika, e-Asia, njll. emazweni nasezifundeni ezingaphezu kuka-60.
